CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS AGREEMENT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 10th, 2022 • Lannett Co Inc • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of March 3, 2022, by and between CHARTWELL CARMEL ASSETS, LLC, a New York limited liability company (“Buyer”), solely for the purposes of Section 10.13, CHARTWELL PHARMACEUTICALS LLC, a Delaware limited liability company (“Chartwell Pharmaceuticals”), SILARX PHARMACEUTICALS, INC., a New York corporation (“Silarx”), LANNETT COMPANY, INC., a Delaware corporation (“Lannett”), and LANNETT HOLDINGS, INC., a Delaware corporation (“Lannett Holdings”) (Silarx, Lannett, and Lannett Holdings, each, a “Seller” and, collectively, the “Sellers”).
CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • May 10th, 2022 • Lannett Co Inc • Pharmaceutical preparations • Delaware
THIS MANUFACTURE AND SUPPLY AGREEMENT (this “Agreement”) is made this 3rd day of March, 2022, by and between CHARTWELL PHARMACEUTICALS CARMEL, LLC, a New York limited liability company, having an address of 77 Brenner Drive, Congers, NY 10920 (“Chartwell”), CHARTWELL PHARMACEUTICALS LLC, a Delaware limited liability company (“Chartwell Pharmaceuticals”), and LANNETT COMPANY, INC. and/or its Affiliates (as defined below), a Delaware corporation having an address of 1150 Northbrook Drive, Suite 155, Trevose, PA 19053, USA (“Lannett”). Lannett and Chartwell are separately referred to as “Party” or jointly as “Parties.”
